Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. | PLoS One | 2021 | 34797837 | PubTator, text mining | PubMed |
| Meta-Analysis of Esophageal Cancer Transcriptomes Using Independent Component Analysis. | Front Genet | 2021 | 34795689 | PubTator, text mining | PubMed |
| Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis. | Taiwan J Obstet Gynecol | 2021 | 34794761 | PubTator, text mining | PubMed |
| Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells. | iScience | 2021 | 34786537 | PubTator, text mining | PubMed |
| Proteomics as a Complementary Technique to Characterize Bladder Cancer. | Cancers (Basel) | 2021 | 34771699 | PubTator, text mining | PubMed |
| Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer. | Cancers (Basel) | 2021 | 34771654 | PubTator, text mining | PubMed |
| Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review. | Cancers (Basel) | 2021 | 34771640 | PubTator, text mining | PubMed |
| Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer. | Cancers (Basel) | 2021 | 34771604 | PubTator, text mining | PubMed |
| Adrenocortical Carcinoma in Childhood: A Systematic Review. | Cancers (Basel) | 2021 | 34771430 | PubTator, text mining | PubMed |
| The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications. | Int J Mol Sci | 2021 | 34769503 | PubTator, text mining | PubMed |
| Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. | MedComm (2020) | 2021 | 34766149 | PubTator, text mining | PubMed |
| Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis. | Sci Rep | 2021 | 34750486 | PubTator, text mining | PubMed |
| The p53 family member p73 in the regulation of cell stress response. | Biol Direct | 2021 | 34749806 | PubTator, text mining | PubMed |
| Functional Genomics of PRUNE1 in Neurodevelopmental Disorders (NDDs) Tied to Medulloblastoma (MB) and Other Tumors. | Front Oncol | 2021 | 34745995 | PubTator, text mining | PubMed |
| Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation. | Front Oncol | 2021 | 34745968 | PubTator, text mining | PubMed |
| Phenotype-tissue expression and exploration (PTEE) resource facilitates the choice of tissue for RNA-seq-based clinical genetics studies. | BMC Genomics | 2021 | 34743696 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Regulatory Factors and Immune-Associated Patterns to Decipher Common and BRCA1/2 Mutation-Type-Specific Critical Regulation in Breast Cancer. | Front Cell Dev Biol | 2021 | 34733851 | PubTator, text mining | PubMed |
| CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20. | Chin Med J (Engl) | 2021 | 34732665 | PubTator, text mining | PubMed |
| Tumor relevant protein functional interactions identified using bipartite graph analyses. | Sci Rep | 2021 | 34728699 | PubTator, text mining | PubMed |
| Prognostic evaluation and immune infiltration analysis of five bioinformatic selected genes in hepatocellular carcinoma. | J Cell Mol Med | 2021 | 34726341 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=49